Primary malignant peripheral nerve sheath tumors (MPNSTs) are extremely rare in patients without a history of neurofibromatosis; only 18 cases have been reported in the English-language literature to this point. The authors report their experience with 1 new case of a primary MPNST. A 33-year-old woman presented with low-back pain radiating to the right calf that progressed over 1 year. Magnetic resonance imaging of the spine revealed an intradural extramedullary lesion at the T12-L1 level. The patient was diagnosed with primary MPNST, underwent two surgical excisions and radiation therapy, and developed leptomeningeal metastases as well as brain metastases. The patient revisited the emergency room with sudden loss of consciousness. A brain CT scan displayed bilateral lateral ventricle enlargement, for which a ventriculoperitoneal shunt was inserted. These symptoms have not been described in any previous report. Primary spinal MPNST is an exceedingly rare entity, and the overall prognosis is very poor. 
M alignant peripheral nerve sheath tumors (MPNSTs) are uncommon types of soft tissue sarcomas that usually arise from peripheral nerve sheaths and rarely involve the spinal roots. These tumors are believed to originate from Schwann cells or pluripotent cells of the neural crest. The estimated incidence of MPNSTs in patients without a history of neurofibromatosis is very low, approximately 0.001%. 7 Malignant peripheral nerve sheath tumors tend to recur locally at the original sites and metastasize to the lungs, liver, lymph nodes, and bones. 10 In this report, we present a case of a primary MPNST at the T-12 and L-1 vertebrae with metastasis to the brain leading to acute hydrocephalus, and provide a detailed clinical and pathological analysis in conjunction with a brief literature review. Ethics approval for this study was provided by the Ethics Committee of Hebei University, and consent to publish the details of this case was obtained from the patient's relatives.
Case Report
History and Examination. A 33-year-old woman with a 1-year history of low-back pain and calf pain on the right side was admitted to the Department of Neurosurgery at Bethune International Peace Hospital. Her radicular pain had increased gradually until she was unable to walk. On physical examination, neither sensory abnormality nor muscle weakness was noted in her upper or lower extremities. The patient's skin demonstrated no superficial stigmata of neurofibromatosis, including café-au-lait spots or terminal nerve twigs. Laboratory examination data were normal. She had no previous medical history or family history of neoplastic disease or neurofibromatosis.
Magnetic resonance imaging revealed a mass approximately 3.4 cm long in the spinal canal from T-12 to L-1 that presented as isointense on a T1-weighted image and slightly hyperintense on a T2-weighted image, which enhanced after Gd administration (Fig. 1) . The tumor had a well-defined contour. It was believed to be a benign tumor, and we decided to remove it surgically.
Operative Course. Complete removal of the tumor was intended. After laminectomy of T-12 and L-1, a longitudinal incision was made at the center of the exposed dura. A dark red, soft, vascular mass, 3.4 cm in length and 2.0 cm in diameter, protruded over the entire area. The spinal cord was severely compressed by the lesion. Following partial resection inside the capsule, the upper and lower boundaries of the tumor were found. The spinal cord and some nerve roots could not be separated from the mass, so partial excision was performed for decompression and diagnosis.
Histopathology and Immunohistochemistry. The excised specimens were subjected to thorough histopathological examination, including H & E staining and immunohistochemistry for S100 protein (Dako), vimentin (Dako), epithelial membrane antigen (Dako), smooth muscle actin (Dako), glial fibrillary acidic protein (GFAP), neurofilament protein, and CD34. Microscopic examination of the surgical specimen revealed a spindle-shaped cell tumor composed of tumor cells arranged in short intersecting fascicles with hypercellularity ( Fig. 2A) . Some cells had increased mitotic activity. Immunohistochemical staining showed tumor cells positive for S100, GFAP, vimentin, and CD34 ( Fig. 2B-E) , but negative for neurofilament protein, smooth muscle actin, and epithelial membrane antigen. These findings were compatible with those of an MPNST.
Postoperative Course. A few days after surgery, the pain had almost completely disappeared, so the patient was not treated with radiation therapy. Four months after the operation, the patient again began to complain of lowback pain radiating to the right calf, increasing muscle weakness in both lower extremities, and urinary dysfunction. Brain MRI demonstrated an intradural lesion from T-12 to L-1 that was slightly larger in size than the previous mass. Removal of the recurrent tumor was attempted. Partial resection was performed because the lesion was strongly adherent to the spinal cord and nerve root. Histopathological examination of operative specimens again resulted in findings compatible with those of an MPNST.
After surgery, the patient's lower extremity muscle strength did not improve. She was treated with radiation therapy (19 fractions of 2800 cGy) for the residual tumor. However, nearly 2 weeks after the second operation, the patient became symptomatic and presented to the emergency department with complaints of visual disturbances. Magnetic resonance imaging revealed that the MPNST had metastasized to all spinal segments, as well as the brain (Fig. 3) . One week later, the patient revisited our emergency room and had been in a coma for 1 hour when she arrived. There was a history of episodic headache accompanied by vomiting preceding this urgent situation. Her right pupil had dilated to 5 mm, and the left pupil had dilated to 2 mm, without any light reflex. A subsequent cranial CT scan showed a communicating hydrocephalus causing dilation of the third and lateral ventricles (Fig. 4) . We administered mannitol 250 ml intravenously guttae and dexamethasone 10 mg intravenously to lower her intracranial pressure, and her consciousness gradually recovered. On the following day in the hospital, the patient had continual seizures. Based on a lumbar puncture, pressure in the CSF was increased, so she underwent ventriculoperitoneal shunt insertion. A Medtronic pump (medium pressure), attached to the peritoneal tubing, was placed during surgery. Surgery was uneventful, and the patient had a benign postoperative course. The patient died 2 years and 5 months after the initial surgery.
Discussion
Malignant peripheral nerve sheath tumors are uncommon malignant neoplasms that originate from diverse cells in the peripheral nerve sheath. Malignant peripheral nerve sheath tumors represent 5% of all malignant softtissue tumors, and only 2%-3% of all MPNSTs originate in the spinal nerves. 8 The reported cases of primary spinal MPNSTs are summarized in Table 1 . To the best of our knowledge, only 18 cases have been found in the English literature (PubMed). In this paper, we aimed to establish the clinical behavior of this rare entity.
Malignant peripheral nerve sheath tumors appear to occur mostly in young patients. Table 1 shows all 18 spinal MPNSTs that have been published in the literature between 1981 and 2012. The mean age of patients with tumors at diagnosis was 35.05 ± 18.90 years (range 4-70 years), and both sexes were equally involved.
Our review of intradural MPNSTs found that 5 (26.32%) were located in the cervical vertebrae, 6 (31.58%) in the thoracic vertebrae, 7 (36.84%) in the lumbar vertebrae, the sacrum, or the cauda equina, and 1 (5.26%) in the spinal accessory. In our case, the MPNST had disseminated throughout the entire spinal cord and metastasized to the brain, which may have occurred via leptomeningeal invasion and metastasis or via CSF circulation.
The most frequently presented complaints were painful radiculopathy (47.37%) and weakness (42.11%). However, our case presented with some atypical symptoms, such as coma and seizures, which were related to the communicating hydrocephalus (Fig. 4) . The primary causes of hydrocephalus could have been obstruction of ependymal cell malfunction or altered production or reabsorption of the CSF, leading to impaired CSF transport and increased intracranial pressure.
The imaging features of the MPNSTs in our case were different from conventional neurilemmomas. The tumors invaded the entire spinal cord, and on MRI, the lesions exhibited enhancement of a "string-of-beads" pattern on T1-weighted imaging (Fig. 3A-C) , which was not described in any previous report. The clinical and neurological status of the patient worsened due to the aggressiveness of the tumor and the brainstem invasion, leading to an increase in CSF pressure and impaired brainstem function.
Histologically, according to the description of the pathological characteristics by Valdueza et al., 12 the most reliable criteria of intracranial MPNSTs are high cellularity, nuclear atypia, and increased mitotic rate, necrosis, and endothelial proliferation. In our patient, some isolated areas had high cellularity with spindle-shaped cells. The mitotic activity was high, and pathological mitotic figures were also detected. The mass was associated with the L-1 spinal and nerve roots. The best treatment for spinal MPNSTs remains poorly defined due to the rarity of the tumor and the lack of prospective trials. Surgery is currently the mainstay of treatment for MPNSTs, and radical resection has been recommended for spinal MPNSTs prior to tumor metastasis. Improved prognosis has been observed after complete removal of the lesions. 7, 8 Surgical removal is useful to not only relieve the complications but also to elucidate the histopathological features of the tumor. In the narrow spinal canal, radical excision of a mass with a margin of normal tissue is hardly ever possible without causing neurological injury. Total excision was achieved in 68.42% of the patients in previous studies (Table 1) . Several studies have recommended the use of en bloc resection of the tumor to improve patient outcome. 11, 14 However, local recurrence and intradural metastases were found postoperatively in these studies. Insufficient removal of the tumor and release of highly malignant cells may be the cause of recurrence and metastases.
The Oncology Consensus Group recommends ad- ministering postoperative radiation therapy as part of a uniform treatment policy for MPNSTs, and some studies have proven that adjuvant radiation therapy may help with local control. 1, 5, 12 However, no significant improvement in survival was observed in a group of patients with MPNSTs located in the trunk and extremities. Acharya et al. 1 indicated that postoperative radiation therapy might help eradicate or suppress residual tumor growth. Of the 19 patients with spinal MPNSTs, 13 underwent radiation therapy. Our patient underwent 2 partial resections and accepted a common intraspinal radiation therapy. The lesion relapsed, and there was leptomeningeal metastasis to the spine and intracranial space. The outcome was poor. Our case demonstrated that radiotherapy was ineffective, and the mass was insensitive to radiation therapy. The role of chemotherapy was unclear, and therefore it should be limited to desperate cases of disseminated metastatic disease. 5, 6 The clinical outcome for patients with spinal MPNSTs has been very poor. The 1-year, 18-month, and 5-year survival rate in this series of primary spinal MPNSTs was 68.42% (13/19), 42.11% (8/19), and 10.53% (2/19), respectively. Even after an apparently complete removal followed by radiation therapy, local recurrence (68.42%, 13/19) and metastases (47.37%, 9/19) were common. The most common sites for metastatic spread were the lungs and the liver, while cerebral metastases were also detected in 4 patients ( Table 1 ). The poorer outcome for spinal MPNSTs is probably due to the surgical challenges posed by their anatomical location, with a greater invasiveness of the tumor, in addition to the rich vascular supply of the spinal canal, which increases the systemic spread. Our patient developed symptomatic recurrence 4 months after the first removal procedure. As the symptoms gradually deteriorated, she underwent reoperation, and the lesion was partially removed. The patient twice received radiation therapy after an operation. She died 1 year after the second operation, with recurrent disease, CNS metastases, and acute hydrocephalus.
Primary spinal MPNSTs are extremely rare, with only 18 such cases previously reported in the English literature. They exhibit aggressive behavior, with a very high recurrence rate even after gross-total resection, and they have significant potential for leptomeningeal and systemic metastasis. In our case, the tumor had disseminated to all spinal segments and the brain, with a communicating hydrocephalus, which is the first such case reported. There is no definite consensus regarding treatment of primary intradural MPNSTs. The optimal management of these tumors largely depends on the personal experience of the treating medical team, and we support surgical tumor removal combined with postoperative radiation therapy. The overall prognosis is very poor. Due to the rarity of this tumor, it is impossible to perform randomized trials. We hope to see more research in the future to improve the prognosis of this disease.
